Immunology News and Research

Latest Immunology News and Research

Researchers develop novel recombinant vaccine against Nipah virus

Nipah virus is a type of RNA virus transmitted from animals to humans. The infection causes severe respiratory illness and symptoms including cough, headache and fever, which can progress into encephalitis, seizure and coma.

15 Apr 2019

Key gene could decrease detrimental brain swelling after stroke

Could a medication someday help the brain heal itself after a stroke, or even prevent damage following a blow to the head? A new USC study lends support to the idea.

15 Apr 2019

Biomolecular researcher provides comprehensive profile of B cells in rheumatoid arthritis

Biomolecular researcher Navin Varadarajan has published in Arthritis & Rheumatology journal a first-of-its-kind study - a comprehensive profile of B cells in rheumatoid arthritis.

12 Apr 2019

Living transplant donors also need long-term monitoring to prevent adverse events

While organ transplant recipients receive continual care as the end-stage treatment to their condition, attention also should be given to living donors, who can suffer from hypertension, diabetes and other disorders after donation, according to a study by researchers at UC San Francisco.

11 Apr 2019

German Research Foundation recently approves new research unit

"Cytomegalovirus, beware of this new research group!" This could be the motto of a new research unit recently approved by the German Research Foundation. It is titled: "Advanced concepts in cellular control of cytomegalovirus ".

11 Apr 2019

Human iPSCs-derived mesenchymal stem cells could avoid ageing-related shortfalls

The use of primary mesenchymal stem cells is fraught with ageing-related shortfalls such as limited expansion and early senescence.

11 Apr 2019

Sexual behavior could affect gut microbiome and immune system

A person's sexual behavior could affect their microbiome and immune system, potentially elevating their risk of HIV infection, according to a new study from researchers at the University of Colorado Anschutz Medical Campus.

10 Apr 2019

Mild cognitive impairment may be present in early stages of kidney disease

The link between brain dysfunction and advanced kidney disease was first noted in 1930, so it is not a new finding.

10 Apr 2019

Key gene involved in transmission of African sleeping sickness identified

Life scientists from UCLA and the University of Bern have identified a key gene in the transmission of African sleeping sickness -- a severe disease transmitted by the bite of infected tsetse flies, which are common in sub-Saharan Africa.

10 Apr 2019

Single-cell sequencing sheds light on landscape of myeloid cells in lung tumors

The recent emergence of immunotherapy has marked a sea change in research and care for many forms of cancer, bringing new hope to patients and families around the world. For those who respond to treatment, the results can be dramatic.

10 Apr 2019

Eight-year study identifies potential new way to treat extreme childhood food allergy

An eight-year hunt for the cells that drive the extreme childhood food allergy eosinophilic esophagitis has identified a potential new way to treat the disease while also raising questions about a dietary supplement often taken to reduce bowel inflammation.

9 Apr 2019

High Throughput Nucleic Acid Purification Simplified

Labs demand purity and flexibility for high throughput nucleic acid purification, while needing to complete difficult downstream analysis, for example NGS.

From Promega Corporation 9 Apr 2019

New technique to test for viral infections discovered

A team of Colorado State University researchers has developed technology that can detect extremely small amounts of antibodies in a person's blood. Antibodies develop to infect cells or kill pathogens, essentially fighting off a bacteria or virus. The levels of antibodies in the blood can tell whether that person is sick.

9 Apr 2019

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

The University of Texas Medical Branch at Galveston, Profectus Biosciences, Vanderbilt University Medical Center, Mapp Biopharmaceutical and Genevant Sciences Corp. have been awarded up to $35 million to advance the development of rapid-acting vaccines and broad-spectrum treatments of the highly-lethal hemorrhagic fever viruses Ebola and Marburg.

9 Apr 2019

Experts detail efforts to improve seasonal and universal influenza vaccine

In a new series of articles, experts in immunology, virology, epidemiology, and vaccine development detail efforts to improve seasonal influenza vaccines and ultimately develop a universal influenza vaccine.

9 Apr 2019

Study of pregnant women with lupus identifies early indicators of pregnancy complications

A study of pregnant women with systemic lupus erythematosus has identified early changes in the RNA molecules present in the blood that could be used to determine the likelihood of them developing preeclampsia.

8 Apr 2019

New study reveals five facts about allergies to vaccines

There is little chance you are actually allergic to vaccines and, if you are, your allergist can give it to you. Only one in 760,000 vaccinations will respond with anaphylaxis. For all other side effects, there are ways around any problem.

8 Apr 2019

Study compares use of breast milk to formula in children who underwent bone marrow transplant

A new pilot study compared the use of human breast milk to formula in children less than 5 years of age who underwent bone marrow transplant (BMT), measuring the levels of inflammatory and pro-inflammatory biomarkers in the stool and blood to assess inflammatory injury to the intestinal microbiome.

5 Apr 2019

UMSOM's Institute for Genome Sciences receives $17.5 million grant for infectious disease research

The Institute for Genome Sciences at the University of Maryland School of Medicine was awarded $17.5 million from the National Institute of Allergy and Infectious Diseases to fund the IGS Genome Center for Infectious Diseases for another five years.

5 Apr 2019

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

The National Institute of Allergy and Infectious Diseases has awarded an international consortium led by Albert Einstein College of Medicine, part of Montefiore, a five-year, $22 million grant to develop antibody-based therapies against four highly lethal viruses for which there are no approved vaccines or treatments.

4 Apr 2019

Immunology News and Research

Latest Immunology News and Research

Researchers develop novel recombinant vaccine against Nipah virus

Key gene could decrease detrimental brain swelling after stroke

Biomolecular researcher provides comprehensive profile of B cells in rheumatoid arthritis

Living transplant donors also need long-term monitoring to prevent adverse events

German Research Foundation recently approves new research unit

Human iPSCs-derived mesenchymal stem cells could avoid ageing-related shortfalls

Sexual behavior could affect gut microbiome and immune system

Mild cognitive impairment may be present in early stages of kidney disease

Key gene involved in transmission of African sleeping sickness identified

Single-cell sequencing sheds light on landscape of myeloid cells in lung tumors

Eight-year study identifies potential new way to treat extreme childhood food allergy

High Throughput Nucleic Acid Purification Simplified

New technique to test for viral infections discovered

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

Experts detail efforts to improve seasonal and universal influenza vaccine

Study of pregnant women with lupus identifies early indicators of pregnancy complications

New study reveals five facts about allergies to vaccines

Study compares use of breast milk to formula in children who underwent bone marrow transplant

UMSOM's Institute for Genome Sciences receives $17.5 million grant for infectious disease research

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

eBook: The Ultimate Guide to Successful Immunofluorescence eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production